09.01.2019 10:16:00

Medicover - The Acquisition of the Centre for Genetic Diagnostics Completed

STOCKHOLM, Jan. 9, 2019 /PRNewswire/ --

The earlier announced acquisition of the centre for genetic diagnostics of Dr. Klein, Dr. Rost and colleagues as well as its affiliate IMGM, both located in Martinsried, near Munich, Germany is completed. All necessary approvals have now been granted.

The centre for genetic diagnostics of Dr. Klein, Dr. Rost and colleagues will be consolidated from January 2019. Revenue for the laboratory amounted to around 17 million euro in 2017 with a total number of employees of 160.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations
+46-703033272

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2017, Medicover had revenue around €580 million and 15,900 employees. For more information, go to

This information was brought to you by Cision

The following files are available for download:

The acquisition of centre for genetic diagnostics completed

 

Analysen zu Medicover AB Registered Shs -B-mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Medicover AB Registered Shs -B- 16,68 4,91% Medicover AB Registered Shs -B-